Rating History for Olema Pharmaceuticals (OLMA) by Jefferies
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2026 | Dennis Ding | New Coverage | Buy (N/A) |
40.00 (43.00) |
15.05 (10.51) |
-30.17% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/19/2026 | Dennis Ding | New Coverage | Buy (N/A) |
40.00 (43.00) |
15.05 (10.51) |
-30.17% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||